Sexually dimorphic actions of glucocorticoids: Beyond chromosomes and sex hormones

Annals of the New York Academy of Sciences

Volumn 1317, Issue 1, 2014, Pages 1-6

  Quinn, Matthew ^a   Ramamoorthy, Sivapriya ^a   Cidlowski, John A ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Glucocorticoid receptor; Glucocorticoids; Sex hormone; Sexual dimorphism

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; ESTROGEN; GLUCOCORTICOID; GROWTH HORMONE; HYDROCORTISONE; SEX HORMONE; TESTOSTERONE; TRANSCRIPTION FACTOR;

ARTICLE; CORTICOSTEROID THERAPY; DISEASE COURSE; DRUG RESPONSE; GENE EXPRESSION; HUMAN; INFLAMMATION; MOLECULAR BIOLOGY; NONHUMAN; PATHOLOGY; PROTEIN EXPRESSION; SEX CHROMOSOME; SEX DIFFERENCE; SIGNAL TRANSDUCTION;

GLUCOCORTICOID RECEPTOR; GLUCOCORTICOIDS; SEX HORMONE; SEXUAL DIMORPHISM;

ANIMALS; CHROMOSOMES, HUMAN, X; CHROMOSOMES, HUMAN, Y; FEMALE; GLUCOCORTICOIDS; GONADAL STEROID HORMONES; HUMANS; MALE; RECEPTORS, GLUCOCORTICOID; SEX CHARACTERISTICS;

EID: 84901498676     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.12425     Document Type: Article

References (41)

1. Sinclair, A.H., P. Berta, M. S. Palmer, et al. 1990. A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature 346: 240-244.
2. Yang, X., E.E. Schadt, S. Wang, et al. 2006. Tissue-specific expression and regulation of sexually dimorphic genes in mice. Genome Res. 16: 995-1004.
3. Wang, X., F. Magkos & B. Mittendorfer 2011. Sex differences in lipid and lipoprotein metabolism: it's not just about sex hormones. J. Clin. Endocrinol. Metab. 96: 885-893.
4. Borras, C., J. Sastre, D. Garcia-Sala, et al. 2003. Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males. Free Radic. Biol. Med. 34: 546-552.
5. Guevara, R., F.M. Santandreu, A. Valle, et al. 2009. Sex-dependent differences in aged rat brain mitochondrial function and oxidative stress. Free Radic. Biol. Med. 46: 169-175.
6. Yamamoto, Y., H. Saito, T. Setogawa & H. Tomioka 1991. Sex differences in host resistance to Mycobacterium marinum infection in mice. Infect. Immun. 59: 4089-4096.
7. Pietschmann, P., M. Rauner, W. Sipos & Kerschan-K. Schindl 2009. Osteoporosis: an age-related and gender-specific disease-a mini-review. Gerontology 55: 3-12.
8. Pecori Giraldi, F., M. Moro & F. Cavagnini 2003. Gender-related differences in the presentation and course of Cushing's disease. J. Clin. Endocrinol. Metab. 88: 1554-1558.
9. McCombe, P.A., J.M. Greer & I.R. Mackay 2009. Sexual dimorphism in autoimmune disease. Curr. Mol. Med. 9: 1058-1079.
10. El-Serag, H.B. & K.L. Rudolph 2007. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132: 2557-2576.
11. Bubb, K.J., R.S. Khambata & A. Ahluwalia 2012. Sexual dimorphism in rodent models of hypertension and atherosclerosis. Br. J. Pharmacol. 167: 298-312.
12. Ishikawa, I., K. Maeda, S. Nakai & Y. Kawaguchi 2000. Gender difference in the mean age at the induction of hemodialysis in patients with autosomal dominant polycystic kidney disease. Am. J. Kidney Dis. 35: 1072-1075.
13. Van Den Eeden, S.K., C.M. Tanner, A.L. Bernstein, et al. 2003. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J. Epidemiol. 157: 1015-1022.
14. Dupont, C. & J. Gribnau 2013. Different flavors of X-chromosome inactivation in mammals. Curr. Opin. Cell. Biol. 25: 314-321.
15. Seemayer, T.A., T.G. Gross, R.M. Egeler, et al. 1995. X-linked lymphoproliferative disease: twenty-five years after the discovery. Pediatr. Res. 38: 471-478.
16. Kasper, C.K. & C.H. Buzin 2009. Mosaics and haemophilia. Haemophilia 15: 1181-1186.
17. Migeon, B.R., S. Luo, M. Jani & P. Jeppesen 1994. The severe phenotype of females with tiny ring X chromosomes is associated with inability of these chromosomes to undergo X inactivation. Am. J. Hum. Genet. 55: 497-504.
18. Ohlsson, C., N. Hellberg, P. Parini, et al. 2000. Obesity and disturbed lipoprotein profile in estrogen receptor-alpha-deficient male mice. Biochem. Biophys. Res. Commun. 278: 640-645.
19. McCauley, L.K., T.F. Tozum, K.M. Kozloff, et al. 2003. Transgenic models of metabolic bone disease: impact of estrogen receptor deficiency on skeletal metabolism. Connect Tissue Res. 44(Suppl 1): 250-263.
20. Connor, Barrett-E. 1997. Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture. Circulation 95: 252-264.
21. Lerner, D.J. & W.B. Kannel 1986. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am. Heart J. 111: 383-390.
22. Danaei, G., M.M. Finucane, Y. Lu, et al. 2011. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 378: 31-40.
23. Sinha-Hikim, I., J. Artaza, L. Woodhouse, et al. 2002. Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy. Am. J. Physiol. Endocrinol. Metab. 283: E154-E164.
24. Whirledge, S. & J.A. Cidlowski 2013. Estradiol antagonism of glucocorticoid-induced GILZ expression in human uterine epithelial cells and murine uterus. Endocrinology 154: 499-510.
25. Haskell, S.G. 2003. Selective estrogen receptor modulators. South Med. J. 96: 469-476.
26. Ruige, J.B., A.M. Mahmoud, D. De Bacquer & J.M. Kaufman 2011. Endogenous testosterone and cardiovascular disease in healthy men: a meta-analysis. Heart 97: 870-875.
27. Abbott, R.D., R.J. Garrison, P.W. Wilson, et al. 1983. Joint distribution of lipoprotein cholesterol classes. The Framingham study. Arteriosclerosis 3: 260-272.
28. Freedman, D.S., J.D. Otvos, E.J. Jeyarajah, et al. 2004. Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham Study. Clin. Chem. 50: 1189-1200.
29. Soriguer, F., S. Morcillo, V. Hernando, et al. 2009. Type 2 diabetes mellitus and other cardiovascular risk factors are no more common during menopause: longitudinal study. Menopause 16: 817-821.
30. Hayes-Punzo, A., P. Mulcrone, M. Meyer, et al. 2012. Gonadectomy and dehydroepiandrosterone (DHEA) do not modulate disease progression in the G93A mutant SOD1 rat model of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 13: 311-314.
31. Amiel, S.A., A. Maran, J.K. Powrie, et al. 1993. Gender differences in counterregulation to hypoglycaemia. Diabetologia 36: 460-464.
32. Basu, R., C. Dalla Man, M. Campioni, et al. 2006. Effects of age and sex on postprandial glucose metabolism: differences in glucose turnover, insulin secretion, insulin action, and hepatic insulin extraction. Diabetes 55: 2001-2014.
33. Shapiro, B.H., A.K. Agrawal & N.A. Pampori 1995. Gender differences in drug metabolism regulated by growth hormone. Int. J. Biochem. Cell Biol. 27: 9-20.
34. Rhen, T. & J.A. Cidlowski 2005. Anti-inflammatory action of glucocorticoids-new mechanisms for old drugs. N. Engl. J. Med. 353: 1711-1723.
35. Duma, D., J.B. Collins, J.W. Chou & J.A. Cidlowski 2010. Sexually dimorphic actions of glucocorticoids provide a link to inflammatory diseases with gender differences in prevalence. Sci. Signal. 3: ra74.
36. Eguchi, H., S. Westin, A. Strom, et al. 1991. Gene structure and expression of the rat cytochrome P450IIC13, a polymorphic, male-specific cytochrome in the P450IIC subfamily. Biochemistry 30: 10844-10849.
37. Ahluwalia, A., K.H. Clodfelter & D.J. Waxman 2004. Sexual dimorphism of rat liver gene expression: regulatory role of growth hormone revealed by deoxyribonucleic acid microarray analysis. Mol. Endocrinol. 18: 747-760.
38. Endo, M., Y. Takahashi, Y. Sasaki, et al. 2005. Novel gender-related regulation of CYP2C12 gene expression in rats. Mol. Endocrinol. 19: 1181-1190.
39. Wiwi, C.A. & D.J. Waxman 2005 Role of hepatocyte nuclear factors in transcriptional regulation of male-specific CYP2A2. J. Biol. Chem. 280: 3259-3268.
40. Thangavel, C., E. Boopathi & B.H. Shapiro 2011. Intrinsic sexually dimorphic expression of the principal human CYP3A4 correlated with suboptimal activation of GH/glucocorticoid-dependent transcriptional pathways in men. Endocrinology 152: 4813-4824.
41. Stotland, N. 2001 Gender-based biology. Am. J. Psychiatry 158: 161-162.